1. Feelgood Pharma is the first company to get approvals from the US, Japan, Germany and France for a vaccine to stop the spread of COVID-19. The good news is that the marginal cost of producing each dose is $25 and that one dose is all that is needed to provide lifetime protection. Market research indicates that the elasticity of demand in the USA is -2. The bad news is that everyone has to pay for the vaccine themselves. a) What price should Feelgood Pharma charge in the USA? b) In India and Mexico, the elasticity of vaccine demand is estimated to be -5. Explain how this is likely to affect your pricing decisions in those countries. Would you charge the same price in both? c) The federal government offers you $30 a dose to meet the needs of persons with low incomes who do not have health insurance. You would sell the vaccine to the feds and they would distribute it free through local clinics. How should you respond to this offer